Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats.

Psychopharmacology
James P KesbyDarryl W Eyles

Abstract

Developmental vitamin D (DVD) deficiency has been proposed as a risk factor for schizophrenia. DVD deficiency in neonatal rats is associated with alterations in cellular development, dopamine metabolism, and brain morphology. DVD-deficient adult rats show novelty-induced hyperlocomotion and an enhanced locomotor response to MK-801, which can be ameliorated by pretreatment with the antipsychotic drug haloperidol. In this study, we examined locomotor responses of male and female juvenile and adult rats to a dose range of amphetamine. We also measured dopamine receptor and monoamine transporter densities in adult brain. Female DVD-deficient adult rats displayed an enhanced sensitivity to amphetamine-induced locomotion, an increased dopamine transporter density in the caudate-putamen and increased affinity in the nucleus accumbens compared with control females. By contrast, there were no differences between control and DVD-deficient male rats. Taken together, this suggests an alteration in the development of the dopamine system and on dopamine-mediated behaviors in female DVD-deficient rats, and this may be relevant to the underlying neurobiology of schizophrenia.

References

Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Jan 1, 1981·Pharmacology, Biochemistry, and Behavior·J T Concannon, M D Schechter
May 7, 1982·European Journal of Pharmacology·J B BeckerK A Lorenz
Dec 1, 1995·Archives of General Psychiatry·J W Olney, N B Farber
Aug 19, 1995·Lancet·N C Andreasen
Mar 1, 1995·The American Journal of Clinical Nutrition·M F Holick
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·M LaruelleR B Innis
Feb 1, 1996·Brain Research. Molecular Brain Research·E PuchaczM K Stachowiak
Mar 1, 1997·Developmental Psychobiology·E P Zorrilla
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·A BreierD Pickar
Jan 15, 1998·Schizophrenia Research·E F TorreyR H Yolken
Jul 11, 2000·Acta Psychiatrica Scandinavica. Supplementum·A Leung, P Chue
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·X ZhuangR Hen
Mar 15, 2002·Neuroreport·Bassem F El-Khodor, Patricia Boksa
Jul 2, 2002·The American Journal of Psychiatry·Mary CannonRobin M Murray
Apr 25, 2003·Neuroscience·D EylesF Feron
Aug 2, 2003·Schizophrenia Research·John McGrathStephen Buka
Apr 6, 2004·Brain Research. Brain Research Reviews·Patricia Boksa
Oct 7, 2004·Brain Research. Developmental Brain Research·Pauline KoDarryl Eyles
Dec 31, 2004·The American Journal of Psychiatry·Elizabeth Cantor-Graae, Jean-Paul Selten
Feb 22, 2005·Brain Research·Sandeep D Bhatt, Dean E Dluzen
Mar 15, 2005·Brain Research Bulletin·F FéronD W Eyles
Oct 21, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Q David WalkerCynthia M Kuhn
Aug 26, 2006·Behavioural Brain Research·Thomas H J BurneDarryl W Eyles

❮ Previous
Next ❯

Citations

Sep 14, 2010·Schizophrenia Bulletin·John J McGrathDarryl W Eyles
Oct 27, 2010·Schizophrenia Bulletin·John McGrathDavid St Clair
Jul 18, 2014·Annual Review of Nutrition·Natalie J GrovesThomas H J Burne
Dec 17, 2010·Expert Review of Neurotherapeutics·Wim Veling, Ezra Susser
Dec 17, 2015·Genes, Brain, and Behavior·Zackary A CopeJared W Young
Nov 13, 2015·Genes, Brain, and Behavior·S A Schoenrock, Lisa M Tarantino
Aug 30, 2012·The Psychiatric Clinics of North America·Michael PiperJohn J McGrath
Aug 30, 2011·Best Practice & Research. Clinical Endocrinology & Metabolism·Lauren R HarmsJohn J McGrath
Jun 15, 2011·Seminars in Cell & Developmental Biology·Darryl EylesJohn McGrath
Jun 15, 2011·Molecular and Cellular Endocrinology·James P KesbyJohn J McGrath
Jun 19, 2014·Paediatric and Perinatal Epidemiology·Sarah A KeimMark A Klebanoff
Sep 19, 2015·Nordic Journal of Psychiatry·Qiang ZengRob Hornstra
May 27, 2015·Biochemical Society Transactions·Michael J Berridge
Mar 11, 2015·Behavioural Brain Research·Jazmin E HawesCaitlin S Wyrwoll
Dec 3, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Xiaoying CuiJohn J McGrath
Dec 15, 2012·Behavioural Brain Research·Natalie J GrovesThomas H J Burne
Apr 26, 2016·Scientific Reports·Christina B LeibrockUndine E Lang
May 3, 2016·International Journal of Rheumatic Diseases·Erdem MaraslıSelda Sarıkaya
Nov 22, 2017·International Journal of Molecular Sciences·Carolina Di SommaPaolo Marzullo
Aug 1, 2018·International Journal of Molecular Sciences·Kalina Duszka, Walter Wahli
Jun 24, 2010·Behavioural Pharmacology·Adam StewartAllan V Kalueff
Sep 29, 2011·Psychopharmacology·James P KesbyThomas H J Burne
Jan 29, 2011·Psychopharmacology·Andrea UbbenhorstUndine E Lang
Nov 21, 2018·World Journal of Pediatrics : WJP·Nadia DehbokriSaba Ghaffary
Jul 9, 2020·Case Reports in Psychiatry·David C Fipps, Elisabet Rainey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here